3.4. Treatment with Glucagon-Like Peptide-1 (GLP-1) down-Regulates Inflammation Induced by Diabetes through the Inhibition of NF-κB, Proinflammatory Cytokines and the NLRP3 Inflammasome Pathway. This evidence concerns the gene NFKB1 and diabetes mellitus.